Sara Deola, MD, PhD

Investigator Cell and Gene Therapy Specialist
Advanced Cell Therapy Core

Email: sdeola@sidra.org or sdeola1@sidra.org
Phone: +974 40037553
ORCID: https://orcid.org/0000-0002-3178-1271
Google Scholar: https://scholar.google.com/citations?user=Y6HGtl0AAAAJ&hl=en

https://orcid.org/0000-0002-3178-1271

  • Elnaggar M, Al-Mohannadi A, Kizhakayil D, Raynaud CM, Al-Mannai S, Gentilcore G, Pavlovski I, Sathappan A, Van Panhuys N, Borsotti C, Follenzi A, Grivel JC, Deola S. “Flow-Cytometry Platform for Intracellular Detection of FVIII in Blood Cells: A New Tool to Assess Gene Therapy Efficiency for Hemophilia A”. Mol Ther Methods Clin Dev. (2019) Nov 15;17:1-12.
  • Deola S*, Cugno C, Comoli P, Guido I, Rubert L, Zecca M, Zanolini D, Follenzi A, Langes M, Negri G, Tauber M, Pusceddu I, Cavattoni I, Svaldi M, Wang E, Rutella S, and Marincola FM. “Evidence for CD19B-CD8T Cell Interactions in Blood and Tissues from Patients with Graft-Versus-Host Disease.” Bone Marrow Transplant (2017) 52(3):459-462.
  • Deola S, Panelli MC, Maric D, Selleri S, Dmitrieva NI, Voss CY, Klein H, Stroncek D, Wang E, Marincola FM. “Helper B cells promote cytotoxic T cell survival and proliferation independently of antigen presentation through CD27/CD70 interactions”. J Immunol. (2008) Feb 1;180(3):1362-72.